Sternal bone marrow derived equine multipotent mesenchymal stromal cells (MSCs): investigations considering the sampling site and the use of different culture media by Eydt, Carina et al.
Sternal bone marrow derived equine multipotent
mesenchymal stromal cells (MSCs): investigations
considering the sampling site and the use of different
culture media
Carina Eydt*, Florian Geburek†, Carmen Schr€ock‡, Nina Hambruch*, Karl Rohn§,
Christiane Pfarrer* and Carsten Staszyk‡
*Institute of Anatomy, University of Veterinary Medicine Hannover, Foundation, Bischofsholer Damm 15, Hannover, D-30173, Germany, †Equine Clinic,
University of Veterinary Medicine Hannover, Foundation, B€unteweg 9, Hannover, D-30559, Germany, ‡Institute of Veterinary-Anatomy, -Histology and
-Embryology, Faculty of Veterinary Medicine, Justus-Liebig-University Giessen, Frankfurter Str. 98, Giessen, D-35392, Germany and §Institute of Biometry
and Information Processing, University of Veterinary Medicine Hannover, Foundation, B€unteweg 2, Hannover, D-30559, Germany
Abstract
Aspiration of equine sternal bone marrow is required for the cultivation of bone marrow-derived multipotent
mesenchymal stromal cells (BM-MSCs) for regenerative therapies. For bone marrow aspiration as well as for
MSC cultivation, there is a need to optimize techniques and protocols to enhance MSC harvest at minimized
culture times. In a comparative study bone marrow aspirates from sternebra 4 and 5 were collected at two dif-
ferent positions within the sternebrae, either from 10 mm or from 30 mm dorsal from the ventral margin of the
sternebrae. Accuracy of the puncture depth was confirmed by ultrasonography and computed tomography. Iso-
lated MSCs were cultivated using media supplemented with three alternative sera, i.e. fetal calf serum, stan-
dardized horse serum and autologous serum. Due to morphological characteristics (spherical shape, only thin
layer of hyaline cartilage at the ventral site, reliable bone marrow aspiration from only 10 mm intraosseous
depth), sternebra 5 appeared most suitable for bone marrow aspiration. Cultivation and expansion of BM-
MSCs was most efficient using fetal calf serum.
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Introduction
Aspiration of equine sternal bone marrow is a surgi-
cal procedure conducted for various diagnostic and
therapeutic purposes. For diagnostic purposes,
equine bone marrow is analysed to characterize and
further explain diagnose haematopoietic disorders
and bone marrow-associated neoplastic conditions
(Russell et al. 1994; Sellon 2006). For therapeutic
purposes, sternal bone biopsies are successfully used
for the production of autologous cancellous bone
grafts to repair large bony defects (Richardson et al.
1986; Desevaux et al. 2000). Meanwhile, sternal bone
marrow is commonly used and well recognized as a
source of MSCs for potentially regenerative thera-
pies of musculoskeletal injuries (Smith et al. 2003,
2013, 2014; Fortier & Smith 2008; Goodrich et al.
2008; Smith 2008; Garvican et al. 2014). Bone mar-
row-derived MSCs appear to have the potential to
produce actual tendon matrix rather than scar tissue
which is by contrast associated with the normal path-
way of tendon healing (Frank et al. 1997; Smith et al.
2003; Kajikawa et al. 2007). Although, the aspiration
of bone marrow from the equine sternum is accepted
as a safe method, fatal thoracic and cardiac
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punctures (Jacobs et al. 1983) as well as a case of
pneumopericardium (Durando et al. 2006) have been
described. To avoid complications, a maximum ven-
tro-dorsal insertion depth of the bone marrow aspira-
tion cannula into the sternebrae of 30 mm has been
recommended (Goodrich et al. 2008). Based on
anatomical studies of sternebrae 4–6 the maximum
tolerable insertion depth was adjusted to 10–20 mm
(Kasashima et al. 2011). A recent investigation
showed that sternebrae 4 and 5 are most suitable for
bone marrow aspiration (Eydt et al. 2014). These
sternebrae possess an almost spherical shape and a
dorso-ventral extension of at least 52 mm. On the
basis of these experimental data, an insertion depth
in the median plane of even more than 30 mm is
regarded as safe in warmblood horses (Eydt et al.
2014).
The process of cultivation of equine MSCs from
bone marrow aspirates has been described in
detail in the literature (Smith et al. 2003; Arnhold
et al. 2007; Bourzac et al. 2010; Spaas et al. 2012).
After bone marrow aspiration, it takes however
between 3 and 6 weeks in culture to harvest a
number of cultured MSCs being adequate for
therapeutic purposes (Brems & Jebe 2008; Fortier
& Smith 2008; Goodrich et al. 2008; Reed &
Leahy 2013; Schnabel et al. 2013). Consequently,
efforts were made to optimize the yield of MSCs
by evaluating alternative aspiration techniques and
different cell isolation protocols (Bourzac et al.
2010; Kasashima et al. 2011). In continuation of
these studies, the quality of bone marrow aspirates
obtained from different insertion depths were
compared and the influence of different sera
supplemented to the MSC culture medium was
determined.
Materials and methods
Animals and bone marrow aspiration technique
Sternal bone marrow aspirates were collected from
twelve horses receiving general anaesthesia. Subse-
quently, the animals were euthanized for reasons
unrelated to this study. The horses (five geldings,
seven mares, aged 2–28 years, body mass between
480 and 640 kg) had no history of previous bone
marrow aspiration. All protocols were approved by
the Animal Welfare Commissioner of the University
of Veterinary Medicine Hannover in accordance
with the German Animal Welfare Law (Lower Sax-
ony State Office for Costumer Protection and Food
Safety, 33.9-42502-04-11/0572). Blood was taken
from each horse to extract autologous serum (AS).
Horses were premedicated with 0.6–0.8 mg/kg xyla-
zine (Xylazin 2%, CP-Pharma GmbH, Burgdorf,
Germany). Anaesthesia was induced by 0.05 mg/kg
midazolam (Midazolam B. Braun 5 mg/mL, B.
Braun Melsungen AG, Melsungen, Germany) and
2.2 mg/kg ketamine (Narketan, 100 mg/mL, Veto-
quinol GmbH, Ravensburg, Germany). General
anaesthesia was maintained with isoflurane (Isoflu-
ran CP, CP-Pharma GmbH, Burgdorf, Germany) in
100% oxygen. Mean arterial blood pressure was
maintained at 70–80 mmHg. Horses were positioned
in dorsal recumbency and the area of the sternum
was clipped. After degreasing the skin with soap and
alcohol, acoustic gel was applied and the sternum
was examined ultrasonographically (Logiq E9, GE
Healthcare, Wauwatosa, WI, USA) with a 5–9 MHz
and a 9–15 MHz linear probe parallel and transverse
to the longitudinal axis of the horse. In addition, lon-
gitudinal panoramic ultrasonograms of the caudal
sternal region were produced, using the LOGIQ-
view function of the ultrasound machine. The posi-
tions of the median plane of sternebrae 4 and 5
were determined using longitudinal and transverse
probe positions (Fig. 1). Freeze frames of trans-
verse B-mode ultrasonograms centred on the
respective sternebra were stored (Fig. 1b). Subse-
quently, the distances from the skin surface to the
continuous hyperechoic line representing the ven-
tral margins of the sternebrae, as well as the dis-
tance between skin surface and hypoechoic zone
(cartilage) ventral to the bony sternebrae (Fig. 1b,
arrows) were measured on the ultrasonograms
(Fig. 1b). Hypodermic injection-needles with a
diameter of 22G were used to mark the positions
of sternebrae 4 and 5, i.e. their cranio-caudal exten-
sions and the median plane (Fig. 2). After a stab
incision of the skin above, the centre of sternebrae
4 and 5 with a No. 11 scalpel blade (Helmut Zepf
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Medizintechnik GmbH, Seitingen-Oberflacht, Ger-
many), a Jamshidi needle (11 gauge 9 100 mm, Fa.
Angiotech, Gainesville, FL, USA) was introduced
through the stab incision until a resistance (ventral
margin of the sternebra) was encountered. Then
the distance from the skin to the ventral margin of
the sternebra was marked on the Jamshidi needle
using a sterile marker pen (Kearing, Shanghai
Kearing Stationary Co., Ltd.). Additionally, the
Jamshidi needle was marked for an intended ster-
nal insertion depth of 10 and 30 mm. Subsequently,
the Jamishidi needle was introduced in the median
plane of the respective sternebra with rotating
movements. In each horse, bone marrow aspirates
were taken from sternebrae 4 and 5 at an intraoss-
eous insertion depth of either 10 mm (six horses)
or 30 mm (six horses). In each group (10 mm inser-
tion depth and 30 mm insertion depth), three
horses were sampled, aspirating 5 mL bone marrow
from sternebra 4 and 10 mL from sternebra 5; the
remaining three horses were sampled, aspirating
10 mL bone marrow from sternebra 4 and 5 mL
from sternebra 5. Then bone marrow was collected
in a 20 mL syringe (filled with 0.1 mL/5 mL hep-
arin; Heparin-calcium-12500-ratiopharm, 12500
I.U., Ratiopharm GmbH, Ulm, Germany) and
transported in a refrigerated box to the laboratory.
After surgery, horses were euthanized under general
anaesthesia by intravenous injection of 70 mg/kg
bodyweight pentobarbital.
Clinical computed tomography (cCT) and micro
computed tomography (lCT)
The sternum of each horse was removed after
euthanasia at the ventral third of the costal carti-
lage using a reciprocating saw (EFA 61, EFA Sch-
mid & Wezel GmbH & Co. KG, Maulbronn,
Germany). By use of a clinical CT (BrillianceTM
CT – Big Bore Oncology Scanner, Philips Medical
Systems, Best, Netherlands) each sternum was
scanned as described previously (Eydt et al. 2014).
Additionally, lCT images (XTremeCT, Scanco
Medical AG, Br€uttisellen, Switzerland) were gener-
ated to visualize the bony architecture of sterne-
brae 4 and 5 and the effects of the puncture
procedure (Fig. 3).
Morphometric measurements were taken by
using the computer program AMIRA (version 5.2.0,
Visualization Sciences Group, Merignac Cedex,
Frankreich) as described previously (Eydt et al.
(a)
(b)
Fig. 1 Ultrasonograms of the equine sternum, horse 18 (Mare,
5 years). (a) Longitudinal panoramic image (LOGIQview function).
The ventral bony margins of the sternebrae 3–7 are clearly visble.
The red arrow indicates the distance between sternebrae 5 (ventral
bony margin) and the skin. (b): Transverse B-mode image of sterne-
bra 5. Skin-to-cartilage distance (green double arrow, 19.4 mm) and
skin-to-bone distance (red double arrow, 22.1 mm).
Fig. 2 Ventral view of the sternal region, horse 13 (mare, 23 years).
The median plane of the sternum and the cranial and caudal borders
of sternebrae 4 and 5 were identified by ultrasonography and
marked with hypodermic needles.
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2014). The following measurements were recorded
(Fig. 4):
1. ventro-dorsal distance from the surface of the skin
to the bony sternebra
2. thickness of the cartilage at the ventral margin of
the sternebra
3. distance from the bony ventral margin to the cen-
tre of the sternebra
4. length of the puncture canal.
Isolation and culture of mononuclear cells
(MNCs)
Bone marrow aspirates (sternebrae 4 or 5, 5 or
10 mL, from 10 or 30 mm sternal insertion depth)
were transferred from the collecting syringes to ster-
ile 50 mL plastic tubes (Sarstedt AG & Co,
N€umbrecht, Germany) and stored at 4°C for 24 h to
allow sedimentation. After centrifugation (1000g,
15 min) the plasma layer was removed. Subse-
quently, the remaining cell-rich layer was divided
into two portions and mixed with 10 mL culture
medium (CM) containing 88% DMEM (Dulbecco’s
Modified Eagle Medium, gibco, life technologies
GmbH, Darmstadt, Germany), 1% penicillin-strep-
tomycin (10 000 U/mL, gibco, life technologies
GmbH, Darmstadt, Germany) and 1% MEM
NEAA (MEM Non-Essential Amino Acids Solution,
100x, gibco, life technologies GmbH, Darmstadt,
Germany). The CM was supplemented with either
10% fetal calf serum (FCS, PAA Laboratories
GmbH, Pasching, Austria) or with 10% autologous
serum (AS). Erythrocytes were removed using a cell
strainer (70 lm, BD FalconTM, BD Bioscience, Dur-
ham, NC, USA). MNCs were isolated by density-gra-
dient centrifugation using Easycoll (Biochrom AG,
Berlin, Germany, 1.086 g/mL) in a mixture of 1:1 by
volume. After washing with phosphate-buffered
Fig. 3 Sternebra 5 after bone marrow aspiration. lCT image, longi-
tudinal plane. The puncture canal within the bony, trabecular mesh-
work is clearly visible. No damage or fractures of the bony
trabeculae are evident.
Fig. 4 Equine sternum, clinical CT images,
resolution (1024 9 1024 pixel), horse 7
(gelding, 3 years). For the CT scan, the
sternum was placed ventral side up to pre-
vent impression of the skin. Sternebrae 4
and 5 are enlarged (blue inset) to visualize
performed measurement procedure.
Orange arrow: distance from the bony ven-
tral margin to the centre of the sternebra.
Red arrow: Distance from skin to the bony
margin of the sternebra. Yellow arrow: ven-
tral-to-dorsal thickness of the cartilage at
the ventral aspect of the sternebra. Purple
arrow: length of the intraosseous puncture
canal.
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saline (PBS, gibco, life technologies GmbH, Darm-
stadt, Germany) and centrifugation at 250g for
5 min, cells were resuspended in CM. The cells
were plated in 2500 mm2 cell culture flasks and
incubated at 37°C and 5% CO2. Media were chan-
ged 24 h after seeding and then every second day
until the cells achieved 80% confluence. Culture
characteristics (size, shape and alignment of cells)
were assessed by inverted light microscopy. The
time until 80% confluence was reached was
recorded and cells were trypsinized (0.05% Tryp-
sin-EDTA (1x), gibco, life technologies GmbH,
Darmstadt, Germany) and reseeded at different
densities according to experiments described in the
following. Therefore, FCS cultivated cells were
divided into two parts. Cells were either further
cultivated using 10% FCS or were cultivated using
10% standardized horse serum (SHS, PAA Labora-
tories GmbH, Pasching, Austria). The content of
SHS was gradually increased over two steps of
medium change. Cells that were initially expanded
using CM supplemented with 10% AS were further
cultivated, using 10% AS.
Colony-forming unit (CFU) assay
CFU assays were performed at passage 2 in a 12 well
cell culture plate (Greiner Bio-One GmbH, Fricken-
hausen, Germany). MSCs (supplemented with FCS,
SHS or AS) were plated at 1, 2, 4 and 8 cells/
100 mm2. Culture medium was replaced every sec-
ond day. After 14 days of culture, adherent cells
were washed in PBS, fixed and stained with 1% cre-
syl violet in 100% methanol. Cell colonies containing
more than 20 cells were counted. Calculation of the
CFU efficiency was performed according to the for-
mula: CFU efficiency (%) = (counted CFU /cells
originally seeded) 9 100.
Scratch assay (Wound healing assay)
Scratch assays were performed at passage 2 in a 6-
well cell culture plate (Greiner Bio-One GmbH,
Frickenhausen, Germany) to which a sterile culture
insert (ibidi GmbH, Martinsried, Germany) was
added. A 500-lm thick wall separated each culture
into two 70 lL cell culture reservoirs. MSCs (supple-
mented with FCS, SHS or AS) were plated at a den-
sity of 30 000 cells/70 lL well and cells were
cultivated for 24 h at 37°C and 5% CO2. Subse-
quently, the culture insert was removed creating a
cell-free gap. Cells were further cultivated in a life
cell imaging system (Cell Observer Systems, Zeiss
MicroImaging). Cell-migration and cell-proliferation
was continuously recorded for 24 h with the com-
puter program Axio Vision. Finally, the gap area
overgrown by cells was determined using the picture
processing software Photoshop (Adobe Photoshop,
CS3; Fig. 5).
Statistics
Differences between FCS, AS and SHS were calcu-
lated by one-way analysis of variance with repeated
measurements and post hoc Tukey test both in
scratch-assay as well as in CFU assay. Resulting P-
values of P < 0.05 were considered as statistically
significant. All analyses were performed with the
statistics program SAS (version 9.3; SAS Institute,
Cary, NC, USA).
(a) (b)
Fig. 5 Cultured equine bone marrow
MSCs, scratch-assay. (a) A standardized gap
was created. (b) After 24 h, a certain
amount of the gap area was re-occupied
by cells. The movement of the cells was
recorded by a life cell imaging microscopy.
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Results
Bone marrow aspiration
The ventral contour of each sternebra could be
clearly detected during ultrasonography (Fig. 1),
which allowed determination of the distance between
the skin surface and the ventral bony margin of the
sternebrae. The mean distance between skin and
sternebra measured 26.4  6.4 mm for sternebra 4
and 29.6  7.8 mm for sternebra 5. The use of injec-
tion needles to indicate the positions of sternebrae 4
and 5 (Fig. 2) resulted in a correct positioning of the
Jamshidi needle to aspirate bone marrow from a
sternal insertion depth of 10 mm or 30 mm.
In both, sternebra 4 and sternebra 5, bone marrow
aspiration was always feasible at a calculated sternal
insertion depth of 30 mm. In sternebra 5, bone mar-
row aspiration was also feasible at a calculated ster-
nal insertion depth of 10 mm. In sternebra 4, bone
marrow aspiration from 10 mm insertion depth was
successful in only 2 out of 12 cases.
Depth of the puncture canal
The skin-sternebra distances determined by mea-
surements on cCT images were compared to ultra-
sonographic measurements. Distances determined by
ultrasonography were constantly shorter, for sterne-
bra 4 (6.3  5.8 mm) and for sternebra 5
(8.9  4.5 mm). The sternal insertion depth calcu-
lated during bone marrow aspiration and the actual
insertion depth measured on cCT images differed
constantly. For sternebra 4, the calculated insertion
depth was in almost all cases underestimated by
approximately 9.0  5.5 mm. For sternebra 5, the
calculated insertion depth was also constantly under-
estimated, but by approximately 2.9  2.0 mm. The
puncture canal deviated from an exact ventro-dorsal
orientation in the median plane but was always
placed within the sternebrae.
Measurements of sternebrae 4 and 5
The geometrical centres of the sternebrae were
placed at 32.2  3.3 mm (sternebra 4) and
27.3  3.7 mm (sternebra 5) dorsal to the ventral
bony margin of the sternebrae. In each sternebra, a
centre zone composed of thin and loosely arranged
bony trabeculae was visible in lCT images. This cen-
tre zone was always reached with the bone marrow
aspiration canula when a 30 mm sternal insertion
depth was intended (Fig. 3 and Fig. 4). The thickness
of the ventral cartilage, measured on cCT images
was 12.0  5.0 mm (sternebra 4) and 6.6  2.3 mm
(sternebra 5). The lCT images always showed a
clearly defined puncture canal (Fig. 3). The bony tra-
beculae lining the puncture canal did not present any
signs of fractures or damage. The same applied for
the area surrounding the dorsal end of the puncture
canal, which was the supposed area of bone marrow
aspiration (Fig. 3).
Cultivation of MNCs obtained from sternal bone
marrow aspirates
Regardless of the sampling site (sternebra 4 or 5), of
the sampling technique (aspiration from 10 mm or
30 mm intraosseous depth) and of the aspirated vol-
ume of bone marrow (5 mL or 10 mL), from all bone
marrow aspirates MNCs were successfully isolated
by density gradient centrifugation. Subsequently cul-
tured MNCs gave rise to plastic adherent cell colo-
nies, with self-renewal capacities and fibroblast
morphology (spindle shaped, homogenous size and
parallel cell alignment). Mean culture time until 80%
subconfluence for cell cultures supplemented with
AS was 14  5 days, cell cultures supplemented with
FCS reached 80% subconfluence after 16  6 days.
In two cases, cultivation of cells in the presence of
AS was not successful.
Colony-forming unit assays
Self-renewal capacity and therefore formation of
new cell colonies was obtained in all experimental
cell cultures independent from the supplemented
serum (FCS, AS or SHS). Cells cultured in the pres-
ence of SHS possessed a significant lower self-
renewal capacity (66.3%  17.1%) compared to
cells cultured in the presence of FCS
(99.4%  40.2%, P < 0.0217). There was no differ-
ence in self-renewal capacity between cells cultured
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with FCS and AS and between cells cultured with
AS and SHS (Fig. 6).
Scratch-assay
All cultures contained cells exhibiting the capacity
for cell-migration, independent from the supple-
mented serum (FCS, AS or SHS). Migrating cells
showed typical morphological characteristics, e.g.
asymmetric cell shape with protrusion of lamellipo-
dia. Actual cellular movement was clearly visualized
by life cell imaging. Created gaps in the culture
dishes became re-occupied by cells. This process was
mainly facilitated by cell proliferation rather than by
cell migration. 24 h after gap formation, cells cul-
tured in FCS re-occupied 31.1%  12.8% of the gap
area. Cells cultured in AS re-occupied
27.5%  13.2% and cultures supplemented with AS
re-occupied 21.7%  5.7%. Statistical analyses did
not reveal any significant difference, all P > 0.05
(Fig. 7).
Discussion
The anatomical characteristics of the equine sternum
were evaluated with special regard to the procedure
of sternal bone marrow aspiration by use of a Jam-
shidi needle set. Reported cases of failed sternal
punctures with fatal consequences demonstrated the
potential risks that are associated with this method
(Jacobs et al. 1983; Durando et al. 2006). Fatal inad-
vertent thoracocentesis results from a complete pen-
etration of the sternum due to overestimated sizes of
the sternebrae or due to improper direction of the
instruments. In order to provide a morphological
basis for a safe and efficient bone marrow aspiration
technique, the dimensions, shapes and internal struc-
tures of the sternum and its sternebrae were exam-
ined in previous studies (Kasashima et al. 2011; Eydt
et al. 2014). The data presented here provide addi-
tional information concerning the maximum harvest
of MNCs by use of an optimal and safe puncture
technique. Previous recommendations for a maximal
puncture depth of 10–30 mm for sternebra 5 were
not confirmed by our data. As, the ventro-dorsal
dimension of sternebra 5 measures 52  0.8 mm a
deeper puncture than 30 mm into this sternebra does
not increase the risk of thoracic puncture if per-
formed perpendicularly to the ventral margin of the
sternebra. However, there is no need to aspirate
bone marrow from areas deeper than 10 mm. More-
over, bone marrow from sternebra 5 from 10 mm
depth always contained a sufficient number of vital
MNCs to produce proliferative MSC cultures
in vitro. In contrast, bone marrow yield from sterne-
bra 4 from 10 mm depth appeared to be insufficient
Fig. 6 Efficiency for self-renewal assessed by rate of colony forma-
tion in Colony-forming unit (CFU)-F assays (culture time 14 days,
cresyl violet staining). Significant differences were denoted by a and
b (P < 0.0217). Differences between cells cultured in SHS and FCS
were statistically significant. Box: interquartile range (25%, 75%), hori-
zontal line: median, rectangle: mean, whiskers: range (5%, 95%).
Fig. 7 Efficiency of cell migration and cell proliferation assessed by
24 h scratch assays (width of scratch: 500 lm). No statistical differ-
ences between cells cultured in autologous serum (AS), FCS and SHS
were detected, all P > 0.05. Box: interquartile range (25%, 75%), hori-
zontal line: median, rectangle: mean, whiskers: range (5%, 95%).
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to produce MSC cultures. These differing results
between sternebra 4 and 5 are likely due to a thicker
coverage of cartilage at the ventral margin of sterne-
bra 4 compared to a thin cartilage coverage at the
ventral margin of sternebra 5. The thick cartilage
layer at sternebra 4 may impede the correct determi-
nation of the distance between the skin and the bony
part of the sternebra during ultrasonography. More-
over, it is more difficult to predict in advance, using
ultrasonography, the point at which the needle
encounters resistance and may occure before the
bone of the sternebra. Nevertheless, bone marrow
aspiration from 30 mm insertion depth appeared
always as safe and successful in terms of MSC culti-
vation in both, sternebra 4 and 5.
The analysed lCT data demonstrated that the
insertion of the Jamshidi needle (10 or 30 mm)
causes no significant destruction of the bony trabecu-
lar meshwork. This observation is consistent with
results that demonstrated only minimal histological
destruction of bony trabeculae after sternal bone
marrow aspiration (Kasashima et al. 2011). However,
although the bony structures remain largely intact
after bone marrow aspiration it is unknown whether
the microenvironment, relevant for the re-migration
and homing of bone marrow stem cells, regenerates
sufficiently.
The identification of the optimal puncture site for
bone marrow aspiration differs considerably among
various clinical descriptions. Some authors located
the insertion site for the Jamshidi needle using par-
ticular anatomical landmarks: cartilage of the
xyphoid (Richardson et al. 1986; Kisiday et al. 2013)
or the olecranon tuber (Sellon 2006; Goodrich et al.
2008; Adams et al. 2012; Delling et al. 2012) in com-
bination with given distances, such as 90–100 mm
cranial the cartilago xyphoidea or a hand caudal the
olecranon tuber. In contrast, other authors recom-
mend the identification of the sternebrae by ultra-
sonography as the safest method to determine the
insertion site (Smith et al. 2003; Arnhold et al. 2007;
Kasashima et al. 2011; Godwin et al. 2012). The lat-
ter recommendation has been supported by our
results. Due to the spherical shape of sternebra 4 and
5 it is important to determine the exact position of
the central aspect of the sternebrae to ensure an
optimal insertion of the aspiration needle. Significant
deviations of the needle position from the centre of
the sternebra increase the risk of fatal thoraco- and
pericardiocentesis and hamper a sufficient harvest of
bone marrow. In this investigation, ultrasonography
was a reliable technique to identify the individual
sternebrae and to determine distances between skin
and ventral margin of the sternebrae with an accept-
able accuracy. Differences between ultrasonographic
and cCT measurements of the skin to bone distance
may be explained by the fact that ultrasonography
was preformed after the sternebrae with overlying
tissues had been isolated and freezed. Consequently
potential explanations for the increased thickness
during cCT may be (1) slight inevitable indention of
the body surface by the ultrasound probe, (2)
increase in tissue thickness by contraction of muscles
and skin after isolation of sterna, (3) distension of
soft tissue by the process of freezing.
In terms of efficiency of in vitro cultivation and
expansion of bone marrow derived MSCs, no differ-
ence was detected for bone marrow aspirates of 5
and 10 mL. This finding is in line with results pre-
sented by Kisiday et al. 2013. These authors detected
similar numbers of MSCs between the first 5 mL of
bone marrow aspirate and the second sequential
5 mL of aspirate, but both were significantly greater
than the 50 mL fraction. As expected, bone marrow
aspirates from sternebra 4 and sternebra 5 did not
show differences concerning the efficiency of MSC
cultivation. However, due to morphological charac-
teristics sternebra 5 appears most suitable for bone
marrow aspiration (as described above).
The cultivation of MSCs was successful with all
used media (Cultivation medium supplemented with
either FCS, AS or SHS). However, in two cases, cul-
tivation of MSCs in presence of autologous serum
failed. This unwanted outcome indicates the risks
and disadvantages that are associated with the use of
autologous serum. The quality of autologous serum
in terms of the content of beneficial substances, e.g.
growth factors, and in terms of the presence of
potential pathogens is highly variable amongst indi-
viduals (Erickson et al. 1991; Nimura et al. 2008;
Tekkatte et al. 2011). These general disadvantageous
of autologous serum are reflected by several cell
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culture experiments that demonstrated superior cul-
ture outcomes in the presence of FCS compared to
AS (Kuznetsov et al. 2000; Nimura et al. 2008).
Those observations are consistent with the results
from our study. Although a generalization from our
experimental setting is debatable, FCS appeared to
be the most suitable serum for the in vitro culture
and expansion of equine bone marrow derived
MSCs. FCS was even superior compared to SHS,
which was suggested to combine the advantageous of
a standardized serum and of an allogenic serum
(derived from same species). MSCs that were cul-
tured in SHS for the experiments were initially iso-
lated and expanded in the presence of FCS. Thus,
the cells were gradually accustomed to SHS, a proce-
dure which might have caused suboptimal culture
conditions. Nevertheless, our results are confirmed
by investigations on primary equine bronchial fibrob-
lasts (Franke et al. 2014). Equine bronchial fibrob-
lasts cultured in SHS had a longer confluence and
doubling time and a limited proliferation rate com-
pared to cells cultured in the presence of FCS
.Although the cells investigated by Franke et al.
(2014, equine bronchial fibroblasts) and the cells we
used (equine bone marrow derived MSCs) are of dif-
ferent origin, both cell types are fibroblastic cells.
While it has been shown that FCS promotes in vitro
proliferation of equine fibroblastic cells (Franke
et al. 2014), other cell types, such as neuronal cells,
proliferate preferentially in media containing SHS
(Franke et al. 2014). These findings suggest a com-
plex interaction between particular serum compo-
nents, independent from the donor species, and cell
type specific requirements. To establish an optimal
serum supplementation the cultured cell type and
the intended cellular processes should be considered.
Conclusion
Sternebra 5 appears to be the most suitable site for
the harvest of equine bone marrow. Localization of
the puncture site by use of ultrasonography is recom-
mended to minimize risks and to optimize bone mar-
row aspiration. An intraosseous puncture depth of
only 10 mm guarantees harvest of bone marrow con-
taining vital MNCs for in vitro cultivation and
expansion of equine bone marrow MSCs. Best MSCs
culture characteristics were observed in the presence
of culture medium supplemented with FCS.
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